Compare NSPR & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | SLND |
|---|---|---|
| Founded | 2005 | 1900 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Medical/Dental Instruments | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1M | 64.0M |
| IPO Year | 2009 | N/A |
| Metric | NSPR | SLND |
|---|---|---|
| Price | $1.20 | $1.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | $4.00 |
| AVG Volume (30 Days) | 55.0K | ★ 83.3K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,310,000.00 | N/A |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | $9.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.12 | $0.65 |
| 52 Week High | $2.93 | $5.34 |
| Indicator | NSPR | SLND |
|---|---|---|
| Relative Strength Index (RSI) | 27.44 | 47.02 |
| Support Level | N/A | $1.00 |
| Resistance Level | $2.47 | $1.80 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 34.22 | 41.15 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.